#760USNASDAQ

ISRG

Intuitive Surgical

$369.83USD

Data as of 2026-09-05

Composite Score50.1Average

≤−99

Margin of safety−205%Expensive

Fair value$121.14

Target$249.64

Loss chance61%Moderate-high

SizeLarge cap

SectorHealth Care

Dividend—

TypeCommon stock

Price

Pillar breakdown

0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)

Health Care median (n=163)

Quality
Profit margins & asset efficiency
71
Exceptional
Health Care median (n=163) 51
Value
Price vs fundamentals
23
Poor
Health Care median (n=163) 51
Growth
Revenue & earnings trajectory
72
Exceptional
Health Care median (n=163) 50
Momentum
Recent price strength
9
Poor
Health Care median (n=163) 62
Health
Balance sheet & solvency
76
Exceptional
Health Care median (n=163) 56
Profitability
ROE, ROA, ROIC
75
Exceptional
Health Care median (n=163) 49
Technical
Trend & volatility signals
39
Weak
Health Care median (n=163) 62
Risk
Volatility & drawdown profile
32
Weak
Health Care median (n=163) 47

025405570100

Exceptional (70+)Strong (55–70)Average (40–55)Weak (25–40)Poor (<25)

Pillars not shown: Sentiment, ML (Phase 5+).

Fair price check

4 different valuation methods each estimate what ISRG should be worth, then we compare to today's price.

Heavily overvalued

Models suggest ISRG is far above estimated fair value

Today's price

$369.83

Median fair price

$121.14

-67% vs today's price

Of 3 methods:3 say pricey(1 outlier excluded)

P/E multiplesOvervalued
thinks it's expensive — estimates $249.64, about 32% below today
P/B multiplesOvervalued
thinks it's expensive — estimates $157.82, about 57% below today
Graham (defensive)Overvalued
thinks it's expensive — estimates $84.45, about 77% below today
Residual IncomeOutlier
estimate looks unreliable — estimates $58.95 — likely unreliable

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair: $121.14
Margin of safety(vs fair value): < −99%
Max (ex-outliers): $249.64
Tangible BVPS: $49.22

Extreme Residual-Income estimate

Median of all applicable methods (current price $369.83). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.

Supporting dataRaw fundamentals & data-quality provenance behind the scores above

Raw fundamentals (SEC EDGAR)

Metric	Value
Market cap	$130.65B
Revenue (TTM)	$11.03B
Net income (TTM)	$3.16B
Operating cash flow (TTM)	$3.71B
CapEx (TTM)	$483.80M
Free cash flow (TTM)CFO − CapEx	$3.22B
Total assets	$20.88B
Total liabilities	$2.58B
Stockholders' equity	$18.17B
Cash & equivalents	$2.76B
Shares outstanding	353.28M
EPS (basic)	$8.94
EPS (diluted)	$8.94
P/E ratio (TTM)	41.37

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date: 2026-07-21
Latest period end: 2026-07-16
Filing lag: 46 days
Missing metrics: 6(depreciation_and_amortization, interest_expense, dividends_paid, long_term_debt, short_term_debt, ebitda)